Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Telos Rx vs Vea Health

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #19Desk pick
Telos Rx

The broadest published catalog in the ranking — compounded GLP-1s plus oral and microdosed tirzepatide, PT-141, intranasal NAD+, and recovery peptides — all compounded and not FDA-approved.

$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz

Marked down on: Everything is compounded and not FDA-approved — including all peptides and the NAD+ spray

vs
Dispatch #376
Vea Health

Vea Health is a direct-to-consumer telehealth platform aimed at men's health, performance, and longevity, offering compounded semaglutide and tirzepatide in both oral and injection protocols.

Marked down on: Pricing not shown until after sign-up

Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 55/100 (C) for Vea Health. Vea Health still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Telos Rx

85/100

B

Overall

Vea Health

55/100

C

Price transparency

74
20

State access

62
86

Molecule range

98
51

Onboarding speed

84
74

Support responsiveness

76
65

Licensing & trust

88
50

The spec sheet

FieldTelos RxVea Health
Semaglutide$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks)Not listed on Vea Health's site (checked June 6, 2026)
Tirzepatide$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)Not listed on Vea Health's site (checked June 6, 2026)
CoverageNot listed on Telos Rx's siteAll 50 states
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forPatients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.Men's-health-focused oral and injectable compounded GLP-1.
Desk Score85/100B55/100C

The verdict

Desk pick — Telos Rx

Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 55/100 (C) for Vea Health. Vea Health still holds its ground where its strengths line up with yours.

Choose Telos Rx if…

Patients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.

$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz

Choose Vea Health if…

Men's-health-focused oral and injectable compounded GLP-1.

All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Telos Rx · Vea Health.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.